Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.
Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, Karlsson JM, Huang D, Kimak MA, Lawrence EC, Feingold E, Meriney SD, Brufsky AM, Ferrell RE.
Finegold DN, et al. Among authors: kimak ma.
Clin Cancer Res. 2012 Apr 15;18(8):2382-90. doi: 10.1158/1078-0432.CCR-11-2303. Epub 2012 Feb 20.
Clin Cancer Res. 2012.
PMID: 22351697
Free PMC article.